99 Results

People

  1. Kris
    Kris
  2. Chaft
    Chaft
  3. Rusch
    Rusch
  4. Bajorin
    Bajorin
  5. Gonen
    Gonen
  6. Dang
    Dang
  7. Jones
    Jones
  8. Postow
    Postow
  9. Baselga
    Baselga
  10. Bochner
    Bochner

Groups

  1. Department of Medicine (64)
  2. Solid Tumor Oncology Division (63)
  3. Surgery (41)
  4. Thoracic Oncology (23)
  5. Survivorship Research (20)
  6. Department of Pathology and Laboratory Medicine (15)
  7. Genitourinary Oncology Service (13)
  8. Melanoma Disease Management Team (11)
  9. Center for Pancreatic Cancer Research (10)
  10. Epidemiology and Biostatistics (10)
  1. "neoadjuvant"
Formats
  1. Journal Article (57)
  2. Review (17)
  3. Meeting Abstract (12)
  4. Editorial (8)
  5. Book Section (3)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Department of Medicine (64)
  2. Solid Tumor Oncology Division (63)
  3. Surgery (41)
  4. Thoracic Oncology (23)
  5. Survivorship Research (20)
  6. Department of Pathology and Laboratory Medicine (15)

More Groups

People
  1. Jamie Chaft (16)
  2. Mark Kris (12)
  3. Valerie Rusch (9)
  4. Dean Bajorin (5)
  5. Mithat Gonen (5)
  6. Chau Dang (4)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (9)
  4. 2022 (7)
  5. 2021 (13)
  6. 2020 (7)

More Years

Publications
  1. Journal of Thoracic Oncology (14)
  2. Annals of Oncology (7)
  3. BJU International (4)
  4. Cancer (4)
  5. Journal of Translational Medicine (4)
  6. European Journal of Cancer (3)

More Publications

Publishers
  1. Elsevier Inc. (25)
  2. Wiley Blackwell (14)
  3. Oxford University Press (10)
  4. Springer (8)
  5. Lippincott Williams & Wilkins (7)
  6. Biomed Central Ltd (4)

More Publishers

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Top advances of the year: Neoadjuvant immunotherapy in melanoma
    Editorial

    Chen, M. F.; Postow, M. A.
    Cancer (2025)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant immune-based approach for renal cell carcinoma: Pros, cons, and future directions
    Review

    Marandino, L.; Campi, R.; Amparore, D.; Tippu, Z.; Albiges, L.; Capitanio, U.; Giles, R. H.; Gillessen, S.; Kutikov, A.; Larkin, J.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • LCMC3: Clinical utility of SUVmax on preoperative 18F-FDG PET-CT in resectable NSCLC treated with neoadjuvant atezolizumab
    Meeting Abstract

    Merritt, R.; Patterson, G. A.; Toloza, E. M.; Lee, J. M.; Raz, D. J.; Baciewicz, F.; Weyant, M.; Molena, D.; Isbell, J.; Kim, J.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • LCMC3: Long-term disease-free and overall survival and their association with ctDNA after neoadjuvant atezolizumab for NSCLC
    Meeting Abstract

    Owen, D. H.; Chaft, J. E.; Haura, E. B.; Toloza, E.; Waqar, S. N.; Patterson, G. A.; Finley, D.; Blasberg, J.; Raz, D.; Salgia, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • The NEOLETRIB trial: Neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer
    Journal Article

    Fjermeros, K.; Ghannoum, S.; Geisler, S. B.; Bhargava, S.; Tahiri, A.; Klajic, J.; Lüders, T.; Fongård, M.; Nawaz, M. S.; Bosnjak-Olsen, T.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant treatments for early stage resectable NSCLC: Consensus recommendations from the international association for the study of lung cancer
    Review

    Spicer, J. D.; Cascone, T.; Wynes, M. W.; Ahn, M. J.; Dacic, S.; Felip, E.; Forde, P. M.; Higgins, K. A.; Kris, M. G.; Mitsudomi, T.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitor therapy in locally advanced MSI GI malignancies
    Review

    Harrold, E. C.; Keane, F.; Cercek, A.
    Clinical Advances in Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Artificial intelligence–powered assessment of pathologic response to neoadjuvant atezolizumab in patients with NSCLC: Results from the LCMC3 study
    Journal Article

    Dacic, S.; Travis, W. D.; Giltnane, J. M.; Kos, F.; Abel, J.; Hilz, S.; Fujimoto, J.; Sholl, L.; Ritter, J.; Khalil, F.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • A general approach to patients presenting with locally advanced or distant metastatic disease
    Review

    Smithy, J. W.; Chapman, P. B.
    The Cancer Journal (2024)

    Fulltext@MSK | Save
  • Executive summary of the American Radium Society appropriate use criteria for neoadjuvant therapy for nonmetastatic pancreatic adenocarcinoma: Systematic review and guidelines
    Review

    Jethwa, K. R.; Kim, E.; Berlin, J.; Anker, C. J.; Tchelebi, L.; Abood, G.; Hallemeier, C. L.; Jabbour, S.; Kennedy, T.; Kumar, R.; more...
    American Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save